Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FB9SN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,253
Award facts
- Contract value 100% obligated
- $15,252.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,252.63 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen 2 mL pharmaceutical products on January 22, 2026, with an ultimate completion date of January 23, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle supplying military healthcare programs worldwide with specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor providing essential medical products to federal healthcare systems including the Defense Health Agency, U.S. Coast Guard, and other government healthcare institutions. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements through open competition, with delivery orders ranging from minimal to substantial values and covering multiple therapeutic domains including specialty medications and critical care materials across military treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FB9SN?
SPE2DR26FB9SN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FB9SN worth?
The government has obligated $15,253 on SPE2DR26FB9SN.
Is contract SPE2DR26FB9SN an order under another contract?
Yes. SPE2DR26FB9SN is a delivery order under SPE2DR25D2212, an indefinite delivery contract.
Was contract SPE2DR26FB9SN competed?
The extent of competition for SPE2DR26FB9SN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award